AZN Share PerformanceMore
|52 week high||5,520.0 22/06/17|
|52 week low||3,996.0 06/12/16|
|52 week change||-599.0 (-11.87%)|
|4 week volume||59,565,876 24/07/17|
Latest News« previous» nextMore
18/08/2017 - 16:53 StockMarketWire
Weakness in cigarette sellers and airlines continued to weigh on the FTSE 100, which finished Friday down 0.8% at 7,323. Im...
18/08/2017 - 11:38 StockMarketWire
Thursday's terror attack in Barcelona unnerved the market and caused a slump in airlines, including British Airways own...
18/08/2017 - 08:49 StockMarketWire
The FTSE 100 fell 0.62% to 7,342.42 on Friday morning following Thursday's terror attack in Barcelona, which hurt US an...
18/08/2017 - 07:14 StockMarketWire
AstraZeneca and Merck & Co have announced that Lynparza has received additional and broad approval in the US for ov...
18/08/2017 - 07:00 RNS
RNS Number: 3479O AstraZeneca PLC 18 August 2017 This announcement contains inside information 18 August 2017 07:00 BST LYNPARZA RECEIVES ADDITIONAL AND BROAD APPROVAL IN THE US FOR OVARIAN CANCER Lynparza's new tablet formulation approved as maintenance treatment for women with platinum-sensitive recurrent ovarian ...
16/08/2017 - 09:43 StockMarketWire
AstraZeneca non-executive director Bruce Burlington will retire on 31 August. He is a member of the audit, the nomination...
16/08/2017 - 07:00 RNS
RNS Number: 0963O AstraZeneca PLC 16 August 2017 16 August 2017 07:00 BST ASTRAZENECA NON-EXECUTIVE DIRECTOR RETIREMENT AstraZeneca announced that, on 31 August 2017, Bruce Burlington will retire as a Non-Executive Director of AstraZeneca PLC and as a member of the Audit Committee, the Nomination and Governance Committee, an...
14/08/2017 - 16:30 RNS
RNS Number: 9312N AstraZeneca PLC 14 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: AstraZeneca PLC 1b....
Latest discussion posts More
“ The US Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca and Merck, to include ongoing treatment of patients with recurrent ovarian ...”▼
“I don't think that it would be Pfizer. IF someone is showing an interest my money (a lot of it) would be on Novartis,”▼
“Phizer sniffing around ??”▼
Codes & Symbols
|Symbols||AZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN|